Since this type of macrophage involves the activation of the NLRP3 inflammasome [118], which is characteristic of the chronic low-grade systemic inflammation present in obesity and insulin resistance, the study of postbiotics as a therapeutic option in obesity deserves further investigation [119]. This evidence concerns the gene NLRP3 and obesity disorder.